David D. Chang - 31 Dec 2024 SCHEDULE 13G/A Report for Allogene Therapeutics, Inc. Common Stock (ALLO)

Filing Manager
David D. Chang
Reporting Manager
David D. Chang, M.D., Ph.D.
Security
Allogene Therapeutics, Inc. Common Stock
Symbol
ALLO
Shares outstanding
213,823,588 shares
Disclosed Ownership
10,905,003 shares
Ownership
5.1%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2025, 16:29:26 UTC
Date of event
31 Dec 2024
Next filing
09 May 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
David D. Chang, M.D., Ph.D. 5.1% 10,905,003 7,991,807 2,913,196 /s/ David D. Chang David D. Chang, M.D., Ph.D.
Chang 2006 Family Trust 0.6% 1,201,108 0 1,201,108 /s/ David D. Chang By David D. Chang, M.D., Ph.D., Co-Trustee
JEC 2019 Trust 0.4% 856,044 0 856,044 /s/ David D. Chang By David D. Chang, M.D., Ph.D., Co-Trustee
RTC 2019 Trust 0.4% 856,044 856,044 /s/ David D. Chang By David D. Chang, M.D., Ph.D., Co-Trustee